S. 822 Introduced Health

Scientific EXPERT Act of 2025

A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a process for science-focused drug development meetings led by the Reagan-Udall Foundation for the Food and Drug Administration with respect to drugs for rare diseases and conditions, and for other purposes.

  1. Introduced
  2. Committee
  3. Passed Senate
  4. Passed House
  5. To President
  6. Became law
Sponsor Sen. Klobuchar, Amy [D-MN] Introduced March 3, 2025 Cosponsors 1 (1 R) Latest action March 3, 2025

Summary

The Congressional Research Service has not published a summary of this bill yet.

Congress.gov

Actions

  1. Mar 3, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Mar 3, 2025 Introduced in Senate

Congressional and federal records come from official public sources: the House Clerk, the U.S. Senate, GovInfo and the Library of Congress (bill status), the Federal Register, and the congress-legislators project. They are copied on a schedule and may lag the official record by a few hours; the official sources govern. News and coverage counts are drawn from the 4Search index and reflect what the press published, not 4Search's views. Nothing here is an endorsement of any candidate, party or position. Terms of use.